Astera Labs, Inc. $ALAB Holdings Decreased by Freemont Management S.A.

Freemont Management S.A. trimmed its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 88.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,100 shares of the company’s stock after selling 105,400 shares during the period. Astera Labs makes up about 1.4% of Freemont Management S.A.’s holdings, making the stock its 20th biggest position. Freemont Management S.A.’s holdings in Astera Labs were worth $2,761,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Sumitomo Mitsui Trust Group Inc. lifted its position in Astera Labs by 21.6% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Astera Labs by 94.6% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock worth $9,908,000 after acquiring an additional 53,276 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in shares of Astera Labs by 142.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company’s stock worth $1,028,000 after acquiring an additional 6,677 shares in the last quarter. Harbour Investments Inc. boosted its position in Astera Labs by 207.7% during the second quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock valued at $221,000 after purchasing an additional 1,651 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its position in Astera Labs by 34.5% during the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock valued at $47,208,000 after purchasing an additional 133,961 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 beat on revenue and EPS with strong growth and margins — the company reported $270.6M revenue, 75.7% gross margin and an EPS beat, and management issued solid Q1 guidance that underscores hyperscaler demand. ALAB Q4 Earnings Beat (Zacks)
• Positive Sentiment: Wall‑street analysts still see upside tied to large AI infrastructure customers (NVIDIA, AMD, Amazon, Google) and JPMorgan highlighted Astera as a beneficiary of AI buildout. That underpins medium‑term demand expectations. JPMorgan Upside Note (Benzinga)
• Neutral Sentiment: Analysts/transcripts available — full earnings call transcript and Seeking Alpha pieces provide granular color on product ramps (Scorpio X) and margin trajectory; read if you need detail on guidance cadence into H2/2027. Earnings Analysis & Transcript (Seeking Alpha)
• Neutral Sentiment: Reported short‑interest entries appear to be data anomalies (values show 0 and NaN); no actionable evidence of a meaningful short squeeze or buildup from the published figures. Earnings Call Transcript (MSN)
• Negative Sentiment: Investors are booking profits after a massive run-up; several outlets flagged profit‑taking and a “rich” valuation as reasons for the selloff despite the beat. Profit‑Taking After Earnings (Seeking Alpha)
• Negative Sentiment: Concerns about concentration and deal terms: coverage highlighted Amazon’s reported $6.5B engagement as a “double‑edged sword” (big revenue opportunity but customer concentration/contract risk), which weighed on sentiment. Amazon Deal Concerns (MarketWatch)
• Negative Sentiment: CFO change and other corporate developments introduced near‑term uncertainty; several writeups linked management changes to the intra‑day weakness as investors reassessed execution risk. Slide After Earnings, CFO Change (Benzinga)

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ALAB. Northland Securities upped their target price on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Stifel Nicolaus increased their price objective on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. TD Cowen reiterated a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Morgan Stanley reissued an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $192.89.

Astera Labs Stock Down 11.9%

NASDAQ:ALAB opened at $126.58 on Friday. The company’s 50 day moving average is $164.73 and its 200-day moving average is $174.08. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The firm has a market cap of $21.38 billion, a price-to-earnings ratio of 103.75, a P/E/G ratio of 1.96 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. Astera Labs’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 90,459 shares of the stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares in the company, valued at $231,467,827.50. This represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares in the company, valued at $27,823,452.93. This trade represents a 5.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 576,936 shares of company stock valued at $87,409,540 in the last quarter. Insiders own 12.50% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.